Dmitriy S. Pershin
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.
Journal: Transplantation and cellular therapy
Published: October 23, 2025
Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.
Journal: Transplantation and cellular therapy
Published: October 23, 2025
Calcineurin inhibitor-free GVHD prophylaxis with baricitinib, abatacept, vedolizumab, and reduced-dose PTCy in pediatric acute leukemia: a prospective study: PtCy, baricitinib, abatacept, and vedolizumab to prevent GVHD.
Journal: Transplantation and cellular therapy
Published: September 16, 2025
Long-term outcome of children with acute lymphoblastic leukemia after hematopoietic stem cell transplantation based on ex-vivo alpha-beta T cell depletion.
Journal: Annals of hematology
Published: August 14, 2025
Very early recovery of T cells after alpha/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia.
Journal: Cytotherapy
Published: April 23, 2025
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Journal: Transplantation and cellular therapy
Published: November 02, 2023
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration.
Journal: Cytotherapy
Published: September 11, 2023
CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality.
Journal: Scientific reports
Published: October 26, 2022
Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: July 14, 2022
Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors.
Journal: Vox sanguinis
Published: November 19, 2021
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival.
Journal: Frontiers in molecular biosciences
Published: July 21, 2021
Last Updated: 09/26/2026